Adam Fabisiak

Lodz, LD, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Seasonality analysis of inflammatory bowel disease exacerbations requiring hospitalization: a single-center, retrospective study from Poland.

Seasonality analysis of inflammatory bowel disease exacerbations requiring hospitalization: a single-center, retrospective study from Poland.

Journal: Polish archives of internal medicine

Published: August 20, 2026

Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?

Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: February 09, 2026

A Proof-of-Concept Pilot Study of Contrast-Enhanced Ultrasound as a Potential Alternative to Contrast-Enhanced Magnetic Resonance Imaging in the Surveillance of Hepatocellular Adenoma and Focal Nodular Hyperplasia.

A Proof-of-Concept Pilot Study of Contrast-Enhanced Ultrasound as a Potential Alternative to Contrast-Enhanced Magnetic Resonance Imaging in the Surveillance of Hepatocellular Adenoma and Focal Nodular Hyperplasia.

Journal: Biomedicines

Published: January 07, 2026

Eosinophilic Esophagitis After Radiofrequency Ablation of Barrett's Esophagus in a 41-Year-Old Man.

Eosinophilic Esophagitis After Radiofrequency Ablation of Barrett's Esophagus in a 41-Year-Old Man.

Journal: The American journal of case reports

Published: October 06, 2025

WIN55,212-2 attenuates intestinal fibrosis in a DSS-induced mouse model.

WIN55,212-2 attenuates intestinal fibrosis in a DSS-induced mouse model.

Journal: Pharmacological reports : PR

Published: September 14, 2025

The endocannabinoid system as a therapeutic target in intestinal fibrosis.

The endocannabinoid system as a therapeutic target in intestinal fibrosis.

Journal: Frontiers in pharmacology

Published: July 20, 2025

Rescue therapy with upadacitinib in severe Crohn's disease.

Rescue therapy with upadacitinib in severe Crohn's disease.

Journal: Przeglad gastroenterologiczny

Published: July 18, 2025

The Expression of F2RL1, P2RX2, P2RX3 and P2RY2 in the Esophagus of Patients with Gastroesophageal Reflux Disease and Their Relationship to Reflux Symptoms-A Pilot Study.

The Expression of F2RL1, P2RX2, P2RX3 and P2RY2 in the Esophagus of Patients with Gastroesophageal Reflux Disease and Their Relationship to Reflux Symptoms-A Pilot Study.

Journal: Journal of clinical medicine

Published: January 12, 2025

Association Between Temporomandibular Disorders and Irritable Bowel Syndrome: A Scoping Review.

Association Between Temporomandibular Disorders and Irritable Bowel Syndrome: A Scoping Review.

Journal: Journal of clinical medicine

Published: October 10, 2024

Combined CB1 antagonist AM6545 and NOP agonist SCH221510 worsen DSS-induced colitis in mice.

Combined CB1 antagonist AM6545 and NOP agonist SCH221510 worsen DSS-induced colitis in mice.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: July 04, 2024

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.

Journal: Frontiers in medicine

Published: July 03, 2024

Utility of Contrast-Enhanced Ultrasound in Optimizing Hepatic Abscess Treatment and Monitoring.

Utility of Contrast-Enhanced Ultrasound in Optimizing Hepatic Abscess Treatment and Monitoring.

Journal: Journal of clinical medicine

Published: June 24, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026